MBL2 and hyperinsulinemic hypoglycemia, familial, 4: MBL-2 acts as a gene modifier for CF disease and while MBL deficiency portends worse CF disease pre-transplant [51], likely related to host defense, low levels post-transplant are protective, highlighting the benefit of reduced innate immunity.